EPO Patent Publication: Enhancing Vaccine Immunogenicity
Summary
The European Patent Office has published patent application EP4509185A2 concerning methods for enhancing the immunogenicity of vaccines using oral yeast beta-glucans. The patent application lists Memorial Sloan Kettering Cancer Center as the applicant.
What changed
European Patent Office publication EP4509185A2 details a method for improving the effectiveness of vaccines by administering oral yeast beta-glucans. The patent application, filed by Memorial Sloan Kettering Cancer Center, focuses on enhancing the immunogenicity of poorly immunogenic antigen-specific vaccines.
This publication represents a new patent application and does not impose immediate compliance obligations on regulated entities. However, it indicates potential advancements in vaccine technology and adjuvant development that may influence future pharmaceutical research and development strategies. Companies in the pharmaceutical and biotechnology sectors should monitor patent landscapes for emerging technologies.
Source document (simplified)
METHODS OF ENHANCING IMMUNOGENICITY OF POORLY IMMUNOGENIC ANTIGEN-SPECIFIC VACCINES USING ORAL YEAST BETA-GLUCANS
Publication EP4509185A2 Kind: A2 Mar 18, 2026
Applicants
Memorial Sloan Kettering Cancer Center
Inventors
CHEUNG, Nai-Kong, MODAK, Shakeel, RAGUPATHI, Govind
IPC Classifications
A61K 31/716 20060101AFI20250317BHEP A61K 31/7016 20060101ALI20250317BHEP A61K 39/00 20060101ALI20250317BHEP A61K 39/12 20060101ALI20250317BHEP A61K 39/39 20060101ALI20250317BHEP C07K 16/28 20060101ALI20250317BHEP C07K 16/30 20060101ALI20250317BHEP A61P 31/00 20060101ALI20250317BHEP A61P 31/16 20060101ALI20250317BHEP A61P 35/00 20060101ALI20250317BHEP A61P 1/00 20060101ALI20250317BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.